Nearly half of U.S. adults still believe that the benefits of taking low-dose aspirin daily outweighs the risks — despite new ...

About 800,000 Americans will have a heart attack or stroke this year. While heart disease can affect anyone, the risk substantially rises with age.

Many Americans don't see anything wrong with taking daily low-dose aspirin, even though experts have concluded its risks ...

Many Americans don’t see anything wrong with taking daily low-dose aspirin, even though experts have concluded its ris ...

For years, healthy older adults were advised by doctors to take a low-dose aspirin daily as a way to reduce the risk of heart ...

You've likely seen warnings against taking aspirin as a preventative measure against heart attack and stroke. It isn't quite ...

Aspirin reduced recurrence by 50% in PIK3CA-mutated colorectal cancer, the DCISionRT test earned FDA breakthrough status for predicting radiotherapy benefit in DCIS, and nivolumab plus chemotherapy ...

The global aspirin drug market is poised for substantial growth over the next decade, with its value expected to increase ...

A randomized study has produced some hopeful news for colorectal cancer survivors with an unlikely suspect: the commonly used ...

The TROP2-directed antibody–drug conjugate improved PFS by 2 months over investigator’s choice of chemotherapy but yielded no significant improvement in overall survival.

Copyright 2025 The Associated Press. All Rights Reserved. Leverkusen’s head coach Xabi Alonso looks on ahead of the German Bundesliga soccer match between Borussia ...

Although Bayer’s top-selling drug Xarelto lost market exclusivity in most geographies in 2024, the company still predicts it will see strong growth from the pharma business unit beginning in 2027.